Heads up: we’re still adding older trademarks. Right now we only show US trademarks filed since 2023, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
VAXARRAY
Show more
Class 1: Assays and reagents for vaccine characterization for research purposes; Assays and reagents for virus characterization for research purposes; serological assays and reagents for research purposes; kits composed of assays and reagents for vaccine characterization and virus characterization, and serological assays and reagents all for research purposes; kits composed of assays and reagents for quantifying antigen(s), viral protein(s), serum antibodies, nucleic acids, or polypeptides from vaccines, virus samples, and serum samples for research purposes
Class 9: Kits comprised of laboratory instruments, recorded software, and reagents for quantifying antigen(s), viral protein(s), serum antibodies, nucleic acids, or polypeptides from vaccines, virus samples, and serum samples
Class 42: Testing services for others in the fields of vaccine research and development, and antigen characterization; Testing services for others, namely, testing of samples obtained from vaccine manufacturing processes; development of custom assays for others in the fields of vaccine development, serological testing, nucleic acid detection, immunoactive agent detection; research and development in the fields of vaccine characterization, virus characterization, and serological assays
Class 1 – ChemicalsClass 9 – Software, electronics & scientificClass 42 – Technology & SaaS
Status timeline
- 1 Apr 2023Application filedNew Application Entered
- 22 Dec 2023Assigned to an examining attorneyAssigned To Examiner
- 3 Jan 2024Office action issuedNon-Final Action Written
- 27 Mar 2024Response to office action filedTeas Response To Office Action Received
- 5 Sep 2024Approved for registration (Supplemental Register)Approved For Registration Supplemental Register
- 8 Oct 2024Registered on the Supplemental RegisterRegistered-Supplemental Register
All 17 events
| 2024-10-08 | Registered-Supplemental Register |
| 2024-10-08 | Notice Of Registration Confirmation Emailed |
| 2024-09-05 | Use Amendment Accepted |
| 2024-09-05 | Approved For Registration Supplemental Register |
| 2024-08-29 | Assigned To Lie |
| 2024-08-29 | Correspondence Received In Law Office |
| 2024-08-29 | Teas/Email Correspondence Entered |
| 2024-03-27 | Teas Response To Office Action Received |
| 2024-03-26 | Teas Amendment Of Use Received |
| 2024-03-26 | Use Amendment Filed |
| 2024-03-26 | Amendment To Use Processing Complete |
| 2024-01-03 | Non-Final Action Written |
| 2024-01-03 | Non-Final Action E-Mailed |
| 2024-01-03 | Notification Of Non-Final Action E-Mailed |
| 2023-12-22 | Assigned To Examiner |
| 2023-04-20 | New Application Office Supplied Data Entered |
| 2023-04-01 | New Application Entered |
Goods & services by class
Class 1 Chemicals
Assays and reagents for vaccine characterization for research purposes; Assays and reagents for virus characterization for research purposes; serological assays and reagents for research purposes; kits composed of assays and reagents for vaccine characterization and virus characterization, and serological assays and reagents all for research purposes; kits composed of assays and reagents for quantifying antigen(s), viral protein(s), serum antibodies, nucleic acids, or polypeptides from vaccines, virus samples, and serum samples for research purposes
First use anywhere 1 Nov 2023 · First use in commerce 1 Nov 2023
Class 9 Software, electronics & scientific
Kits comprised of laboratory instruments, recorded software, and reagents for quantifying antigen(s), viral protein(s), serum antibodies, nucleic acids, or polypeptides from vaccines, virus samples, and serum samples
First use anywhere 1 Nov 2023 · First use in commerce 1 Nov 2023
Class 42 Technology & SaaS
Testing services for others in the fields of vaccine research and development, and antigen characterization; Testing services for others, namely, testing of samples obtained from vaccine manufacturing processes; development of custom assays for others in the fields of vaccine development, serological testing, nucleic acid detection, immunoactive agent detection; research and development in the fields of vaccine characterization, virus characterization, and serological assays
First use anywhere 5 Jan 2022 · First use in commerce 5 Jan 2022
Source & freshness
Source: the official United States trademark register. This record was last updated on 8 Oct 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.